The Global Need for Effective Antibiotics
A section of Antibiotics (ISSN 2079-6382).
Section Information
The emerging problem of antimicrobial resistance poses a serious threat to public health around the world. Furthermore, this situation is exacerbated by the significant decline in antimicrobial research and development. Very few new classes of antimicrobials enter the market as older classes lose their effectiveness. Going forward, the goal is to meet the challenge of developing new therapies and to maintain the effectiveness of existing therapies to meet the future need for effective antibiotics.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Strategies for Combatting Multidrug-Resistant and Extensively Drug-Resistant Bacteria, 3rd Edition (Deadline: 30 June 2026)
- Advances in Antimicrobial Compounds: Exploring Natural, Synthetic, and Repositioned Drugs (Deadline: 31 July 2026)
- Repositioning Drugs as a Strategy to Combat Infections (Deadline: 31 July 2026)
- Gram-Negative Infections in Humans and Companion Animals: A Global Threat (Deadline: 31 July 2026)
- The Global Antibiotic Imperative: Bridging Access, Stewardship, and Innovation (Deadline: 15 November 2026)
- Modern Strategies in Antibacterial Discovery: Integrating In Silico Predictions with In Vitro Validation (Deadline: 30 April 2027)
